Idoxuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11IN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LGP81V5245, chemically known as uridine, 5-iodo-2-deoxy- but generally known as idoxuridine, which bears US NIH Compound Identifier 3687. European Medicines Agency schedules Idoxuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08117MIG. The term IDOXURIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules idoxuridine in its Anatomical Therapeutic Chemical (ATC) Classification. IDOXURIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idoxuridine under HS 29349990 and SITC 51579. As of Q4 2014, IDOXURIDINE remains the US FDA Preferred Term for this commodity. Idoxuridine bears US NLM identifiers UMLS ID C0020811 and NCI Concept Code C563. SMILES: IC1CN(C2OC(C(O)C2)CO)C(=O)[NH]C1=O.